The genetic alterations most often observed are the ones already described in PTC and FTC with the exception of RET/PTC and PAX8/PPARγ rearrangements, but in addition also include mutations in TP53 and β-catenin genes. Here, RET is linked to thyroid cancer, nonmedullary, 2.